Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010202

Options or other derivatives

  • Director acquired 89,016 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FORBES CHRISTOPHER · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-19 Grant or award : show line 1 in the form Common Stock Option +89,016 $0.15 2018-02-19 89,016 1,495,821 D
Loading xslF345X03/form457955_20130220025836-.xml…